These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1148867)

  • 21. Effects of LSD and 2-bromo LSD on striatal DOPAC levels.
    Persson SA
    Life Sci; 1977 Apr; 20(7):1199-205. PubMed ID: 15175
    [No Abstract]   [Full Text] [Related]  

  • 22. Interaction between LSD and dopamine D2/3 binding sites in pig brain.
    Minuzzi L; Nomikos GG; Wade MR; Jensen SB; Olsen AK; Cumming P
    Synapse; 2005 Jun; 56(4):198-204. PubMed ID: 15803496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of serotonin and dopamine receptors in Aplysia tissues: analysis by [3H]LSD binding and adenylate cyclase stimulation.
    Drummond AH; Bucher F; Levitan IB
    Brain Res; 1980 Feb; 184(1):163-77. PubMed ID: 7357415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of lysergic and diethylamide (LSD) and 2-bromolysergic acid diethylamide (BOL) on the striatal DOPA accumulation: influence of central 5-hydroxytryptaminergic pathways.
    Persson SA; Johansson H
    Brain Res; 1978 Mar; 142(3):505-13. PubMed ID: 25117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Daily LSD administration selectively decreases serotonin2 receptor binding in rat brain.
    Buckholtz NS; Freedman DX; Middaugh LD
    Eur J Pharmacol; 1985 Mar; 109(3):421-5. PubMed ID: 3987809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proceedings: Action of LSD on supersensitive mesolimbic dopamine receptors.
    Kelly PH
    Br J Pharmacol; 1975 Oct; 55(2):291P. PubMed ID: 1201419
    [No Abstract]   [Full Text] [Related]  

  • 28. d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.
    De Gregorio D; Comai S; Posa L; Gobbi G
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Letter: LSD and dopamine receptors.
    Pycock C; Anlezark G
    Nature; 1975 Sep; 257(5521):69-70. PubMed ID: 1161009
    [No Abstract]   [Full Text] [Related]  

  • 30. Lisuride- and D-LSD-induced changes of monoamine turnover in the rat brain.
    Keller HH; Burkard WP; Pieri L; Bonetti EP; Da Prada M
    Adv Biochem Psychopharmacol; 1978; 19():393-6. PubMed ID: 696467
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis.
    Pieri L; Keller HH; Burkard W; Da Prada M
    Nature; 1978 Mar; 272(5650):278-80. PubMed ID: 203869
    [No Abstract]   [Full Text] [Related]  

  • 32. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homovanillic acid levels in corpus striatum, limbic system and diencephalon of male and female rats.
    Leret ML; Olid JM; Martínez-Conde E
    Rev Esp Fisiol; 1984 Dec; 40(4):489-92. PubMed ID: 6531512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synaptosomal uptake and release of dopamine and 5-hydroxy-tryptamine in the nucleus accumbens in vitro following in vivo administration of lysergic acid diethylamide in rats.
    Hetey L; Quiring K
    Acta Biol Med Ger; 1980; 39(8-9):889-95. PubMed ID: 7282218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D-lysergic acid diethylamide (LSD)--effect on biogenic amines excretion in man.
    Messiha FS; Grof S
    Biochem Pharmacol; 1973 Sep; 22(18):2352-4. PubMed ID: 4733686
    [No Abstract]   [Full Text] [Related]  

  • 36. The dopamine receptor: differential binding of d-LSD and related agents to agonist and antagonist states.
    Creese I; Burt DR; Synder SH
    Life Sci; 1975 Dec; 17(11):1715-9. PubMed ID: 1207384
    [No Abstract]   [Full Text] [Related]  

  • 37. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin-sensitive adenylate cyclase activity of immature rat brain.
    von Hungen K; Roberts S; Hill DF
    Brain Res; 1975 Feb; 84(2):257-67. PubMed ID: 1078637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal learning enhanced by lysergic acid diethylamide (LSD): concomitant rise in brain 5-hydroxytryptamine levels.
    King AR; Martin IL; Melville KA
    Br J Pharmacol; 1974 Nov; 52(3):419-26. PubMed ID: 4458849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LSD: effect on monoamine metabolites in rat prefrontal cortex.
    Bowers MB; Salomonsson LA
    Biochem Pharmacol; 1982 Dec; 31(24):4093-6. PubMed ID: 6186259
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.